Para sífilis? Benzetacil.
Para gonorreia? Ceftriaxona.
Para clamídia? Doxiciclina.
Para hepatite B? Tenofovir.
Para hepatite C? Daclatasvir + sofosbuvir.
Para cancro mole? Azitromicina.
Para HPV? Cauterização/cirurgia.
Para todas?
Cuidado centrado em cada indivíduo. ❤️🩹
Para gonorreia? Ceftriaxona.
Para clamídia? Doxiciclina.
Para hepatite B? Tenofovir.
Para hepatite C? Daclatasvir + sofosbuvir.
Para cancro mole? Azitromicina.
Para HPV? Cauterização/cirurgia.
Para todas?
Cuidado centrado em cada indivíduo. ❤️🩹
April 23, 2026 at 3:19 PM
Para sífilis? Benzetacil.
Para gonorreia? Ceftriaxona.
Para clamídia? Doxiciclina.
Para hepatite B? Tenofovir.
Para hepatite C? Daclatasvir + sofosbuvir.
Para cancro mole? Azitromicina.
Para HPV? Cauterização/cirurgia.
Para todas?
Cuidado centrado em cada indivíduo. ❤️🩹
Para gonorreia? Ceftriaxona.
Para clamídia? Doxiciclina.
Para hepatite B? Tenofovir.
Para hepatite C? Daclatasvir + sofosbuvir.
Para cancro mole? Azitromicina.
Para HPV? Cauterização/cirurgia.
Para todas?
Cuidado centrado em cada indivíduo. ❤️🩹
Para sífilis? Benzetacil.
Para gonorreia? Ceftriaxona.
Para clamídia? Doxiciclina.
Para hepatite B? Tenofovir.
Para hepatite C? Daclatasvir + sofosbuvir.
Para cancro mole? Azitromicina.
Para HPV? Cauterização/cirurgia.
Para todas?
Rastreio, conscientização e prevenção focada em cada indivíduo. ❤️🩹
Para gonorreia? Ceftriaxona.
Para clamídia? Doxiciclina.
Para hepatite B? Tenofovir.
Para hepatite C? Daclatasvir + sofosbuvir.
Para cancro mole? Azitromicina.
Para HPV? Cauterização/cirurgia.
Para todas?
Rastreio, conscientização e prevenção focada em cada indivíduo. ❤️🩹
September 22, 2024 at 2:23 PM
Para sífilis? Benzetacil.
Para gonorreia? Ceftriaxona.
Para clamídia? Doxiciclina.
Para hepatite B? Tenofovir.
Para hepatite C? Daclatasvir + sofosbuvir.
Para cancro mole? Azitromicina.
Para HPV? Cauterização/cirurgia.
Para todas?
Rastreio, conscientização e prevenção focada em cada indivíduo. ❤️🩹
Para gonorreia? Ceftriaxona.
Para clamídia? Doxiciclina.
Para hepatite B? Tenofovir.
Para hepatite C? Daclatasvir + sofosbuvir.
Para cancro mole? Azitromicina.
Para HPV? Cauterização/cirurgia.
Para todas?
Rastreio, conscientização e prevenção focada em cada indivíduo. ❤️🩹
About a decade ago, we found a reliable cure for Hep C, sofosbuvir, which has made around $100B for drug companies.
You take it for 12 weeks. Your Hep C is cured. The end.
You take it for 12 weeks. Your Hep C is cured. The end.
April 19, 2026 at 12:11 AM
About a decade ago, we found a reliable cure for Hep C, sofosbuvir, which has made around $100B for drug companies.
You take it for 12 weeks. Your Hep C is cured. The end.
You take it for 12 weeks. Your Hep C is cured. The end.
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus
#IDSky
#IDSky
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus
Treatment of hepatitis C virus (HCV) during pregnancy can cure maternal HCV and prevent perinatal HCV transmission. The primary objective was to compare the pharmacokinetics (PK) of sofosbuvir (SOF)/velpatasvir (VEL) in pregnant versus nonpregnant people.
academic.oup.com
May 11, 2025 at 6:58 PM
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People With Hepatitis C Virus
#IDSky
#IDSky
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People with Hepatitis C Virus
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People with Hepatitis C Virus
Treatment of hepatitis C virus (HCV) during pregnancy can cure maternal HCV and prevent perinatal HCV transmission. The primary objective was to compare the pharmacokinetics (PK) of sofosbuvir/velpatasvir (SOF/VEL) in pregnant versus nonpregnant people.
buff.ly
December 21, 2024 at 1:41 PM
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People with Hepatitis C Virus
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Then, while I onboard those interventions, acquire truvada and sofosbuvir so we can discuss and try an antiviral combo after our next visit. The sofosbuvir will be coming from India so it’ll take a while to get to me.
December 20, 2024 at 10:51 PM
Then, while I onboard those interventions, acquire truvada and sofosbuvir so we can discuss and try an antiviral combo after our next visit. The sofosbuvir will be coming from India so it’ll take a while to get to me.
Everything is shit but the Sofosbuvir I ordered from abroad is almost here so once I get back to baseline post-rapamycin my doc and I can start my antiviral combo!!! I know truvada and Sofosbuvir don’t work for everyone, but they’ve worked for some and I just really need a #LongCOVID win these days.
January 28, 2025 at 10:31 PM
Everything is shit but the Sofosbuvir I ordered from abroad is almost here so once I get back to baseline post-rapamycin my doc and I can start my antiviral combo!!! I know truvada and Sofosbuvir don’t work for everyone, but they’ve worked for some and I just really need a #LongCOVID win these days.
In CID, Catherine Chappell, MD MSc, and colleagues compare the pharmacokinetics (PK) of sofosbuvir/velpatasvir (SOF/VEL) in pregnant versus nonpregnant people.
Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People with Hepatitis C Virus
Treatment of hepatitis C virus (HCV) during pregnancy can cure maternal HCV and prevent perinatal HCV transmission. The primary objective was to compare the pharmacokinetics (PK) of sofosbuvir/velpatasvir (SOF/VEL) in pregnant versus nonpregnant people.
academic.oup.com
December 26, 2024 at 7:33 PM
In CID, Catherine Chappell, MD MSc, and colleagues compare the pharmacokinetics (PK) of sofosbuvir/velpatasvir (SOF/VEL) in pregnant versus nonpregnant people.
Using AI to try to identify/repurpose antiviral compounds that may work well against HPAI: sofosbuvir and GS441524 good candidates, but need to be validated.
👉 www.mdpi.com/1999-4915/17...
👉 www.mdpi.com/1999-4915/17...
July 17, 2025 at 1:22 AM
Using AI to try to identify/repurpose antiviral compounds that may work well against HPAI: sofosbuvir and GS441524 good candidates, but need to be validated.
👉 www.mdpi.com/1999-4915/17...
👉 www.mdpi.com/1999-4915/17...
#SUS tem novo tratamento para #HepatiteC crônica em crianças:
#Sofosbuvir 200 mg / #Velpatasvir 50 mg.
tvtnews.com.br/sus-novo-tra...
#SaúdeInfantil
#GovernoLula
#Sofosbuvir 200 mg / #Velpatasvir 50 mg.
tvtnews.com.br/sus-novo-tra...
#SaúdeInfantil
#GovernoLula
SUS tem novo tratamento para hepatite C crônica em crianças
Nova formulação do SUS facilita a aceitação por crianças que tenham dificuldade de engolir comprimido
tvtnews.com.br
January 9, 2026 at 1:35 AM
#SUS tem novo tratamento para #HepatiteC crônica em crianças:
#Sofosbuvir 200 mg / #Velpatasvir 50 mg.
tvtnews.com.br/sus-novo-tra...
#SaúdeInfantil
#GovernoLula
#Sofosbuvir 200 mg / #Velpatasvir 50 mg.
tvtnews.com.br/sus-novo-tra...
#SaúdeInfantil
#GovernoLula
Since I can’t take any of the US antivirals OR ensitrelvir to try to treat my #LongCOVID, I’m now looking at Sofosbuvir (Hep C antiviral that may be effective against SC2). Anyone take it? What have your experiences been?
December 15, 2024 at 11:11 PM
Since I can’t take any of the US antivirals OR ensitrelvir to try to treat my #LongCOVID, I’m now looking at Sofosbuvir (Hep C antiviral that may be effective against SC2). Anyone take it? What have your experiences been?
My second installment of "Classics in Medicinal Chemistry" describes the design and development of a truly revolutionary drug for treating Hepatitis C. It's a masterclass in medicinal chemistry and biochemistry detective work. medchemash.substack.com/p/classics-i...
Classics in Medicinal Chemistry #2: Sofosbuvir
Sovaldi
medchemash.substack.com
January 21, 2025 at 9:44 PM
My second installment of "Classics in Medicinal Chemistry" describes the design and development of a truly revolutionary drug for treating Hepatitis C. It's a masterclass in medicinal chemistry and biochemistry detective work. medchemash.substack.com/p/classics-i...
At Johns Hopkins, Iowa State, and University of Minnesota, scientists found that SARS-CoV-2 evades key antivirals like bemnifosbuvir and sofosbuvir by shifting viral RNA from the polymerase to a proofreading enzyme that cuts the drugs out.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Client Challenge
www.nature.com
January 14, 2026 at 9:54 PM
At Johns Hopkins, Iowa State, and University of Minnesota, scientists found that SARS-CoV-2 evades key antivirals like bemnifosbuvir and sofosbuvir by shifting viral RNA from the polymerase to a proofreading enzyme that cuts the drugs out.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
I’m on day 5 of Sofosbuvir. The first two days I only took one pill, but have been taking 2 the other two days. Very up and down but the ups are very up. My nervous system feels very calm on those days.
February 11, 2025 at 11:59 PM
I’m on day 5 of Sofosbuvir. The first two days I only took one pill, but have been taking 2 the other two days. Very up and down but the ups are very up. My nervous system feels very calm on those days.
Interrupted research in life sciences is dead patients. My Dad died of hepatitis C in 2013, just as the interferon free drugs arrived. NIH investments saved many lives via those drugs, just not fast enough. pmc.ncbi.nlm.nih.gov/articles/PMC...
Public funding for transformative drugs: the case of sofosbuvir
Transformative drugs often emerge from investment by public and private actors. Sofosbuvir changed hepatitis C care, but had public support through NIH. An estimated $60.9 million in public dollars su...
pmc.ncbi.nlm.nih.gov
July 24, 2026 at 1:17 PM
Interrupted research in life sciences is dead patients. My Dad died of hepatitis C in 2013, just as the interferon free drugs arrived. NIH investments saved many lives via those drugs, just not fast enough. pmc.ncbi.nlm.nih.gov/articles/PMC...
New at @lancetchildadol.bsky.social - Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry study
www.thelancet.com/journals/lan...
#LiverSky #HepSky
www.thelancet.com/journals/lan...
#LiverSky #HepSky
Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry study
No change in growth or sexual development was detected during prolonged follow-up
of paediatric patients who had completed treatment with sofosbuvir-based direct-acting
antivirals for chronic HCV. Pro...
www.thelancet.com
April 1, 2025 at 1:59 PM
New at @lancetchildadol.bsky.social - Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry study
www.thelancet.com/journals/lan...
#LiverSky #HepSky
www.thelancet.com/journals/lan...
#LiverSky #HepSky
Sofosbuvir-daclatasvir proved equally effective as sofosbuvir-velpatasvir, offering promising treatment strategies for hepatitis C.
by Cooke GS, Hung LM (...) Walker AS et 28 al. in Lancet #MedSky
👉 get more here
📖 read the article:
by Cooke GS, Hung LM (...) Walker AS et 28 al. in Lancet #MedSky
👉 get more here
📖 read the article:
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial
WHO recommends treating hepatitis C infection with one of three antiviral combinations for 8–12 weeks. No randomised trials have compared these regime…
www.sciencedirect.com
May 26, 2025 at 2:34 PM
#OTILT is that combining sofosbuvir with amiodarone can cause bradycardia, and this interaction should be avoided.
@bwdionne.bsky.social
@jeffpears0n.bsky.social
@saanyav.bsky.social
pmc.ncbi.nlm.nih.gov/articles/PMC...
@bwdionne.bsky.social
@jeffpears0n.bsky.social
@saanyav.bsky.social
pmc.ncbi.nlm.nih.gov/articles/PMC...
Checking your browser - reCAPTCHA
pmc.ncbi.nlm.nih.gov
May 20, 2026 at 7:22 PM
#OTILT is that combining sofosbuvir with amiodarone can cause bradycardia, and this interaction should be avoided.
@bwdionne.bsky.social
@jeffpears0n.bsky.social
@saanyav.bsky.social
pmc.ncbi.nlm.nih.gov/articles/PMC...
@bwdionne.bsky.social
@jeffpears0n.bsky.social
@saanyav.bsky.social
pmc.ncbi.nlm.nih.gov/articles/PMC...
New data presented by Datuk Dr Radzi Abu Hassan at the 2025 #EASLCongress showed that the ravidasvir/sofosbuvir treatment can be safely shortened from 12 to 8 weeks. This shorter regimen is intended for people living with #HepC who do not have cirrhosis.
Link to the poster: dndi.org/wp-content/u...
Link to the poster: dndi.org/wp-content/u...
June 30, 2025 at 11:20 AM
New data presented by Datuk Dr Radzi Abu Hassan at the 2025 #EASLCongress showed that the ravidasvir/sofosbuvir treatment can be safely shortened from 12 to 8 weeks. This shorter regimen is intended for people living with #HepC who do not have cirrhosis.
Link to the poster: dndi.org/wp-content/u...
Link to the poster: dndi.org/wp-content/u...
Unfortunately - this doesn't Fact Check because they are ALL available generic. At Walmart and likely LESS at CostPlus but....
Albuterol - $34
Atorvastatin - $9
Azithromycin - $8
Sofosbuvir - $9k (that is ridiculous)
Stop inflating by quoting the brand price when generics are readily available.
Albuterol - $34
Atorvastatin - $9
Azithromycin - $8
Sofosbuvir - $9k (that is ridiculous)
Stop inflating by quoting the brand price when generics are readily available.
September 12, 2025 at 8:57 PM
Unfortunately - this doesn't Fact Check because they are ALL available generic. At Walmart and likely LESS at CostPlus but....
Albuterol - $34
Atorvastatin - $9
Azithromycin - $8
Sofosbuvir - $9k (that is ridiculous)
Stop inflating by quoting the brand price when generics are readily available.
Albuterol - $34
Atorvastatin - $9
Azithromycin - $8
Sofosbuvir - $9k (that is ridiculous)
Stop inflating by quoting the brand price when generics are readily available.
"É inaceitável que, após uma luta tão longa para garantir a produção de genéricos e romper o monopólio da Gilead, o Brasil continue pagando caro pelo sofosbuvir. Permanecer pagando preços inflacionados é uma afronta ao direito à saúde e à boa gestão dos recursos públicos."
COMO PATENTES ATRASAM O COMBATE ÀS HEPATITES
Para prolongar lucros com sofosbuvir, remédio que cura a hepatite C, empresa dos EUA chegou a bloquear genérico no Brasil – encarecendo e dificultando ações contra a doença. Reforçar soberania em tecnologias de saúde se mostra essencial
Para prolongar lucros com sofosbuvir, remédio que cura a hepatite C, empresa dos EUA chegou a bloquear genérico no Brasil – encarecendo e dificultando ações contra a doença. Reforçar soberania em tecnologias de saúde se mostra essencial
Como patentes atrasam o combate às hepatites | Outras Palavras
Para prolongar lucros com sofosbuvir, remédio que cura a hepatite C, empresa dos EUA chegou a bloquear genérico no Brasil – encarecendo e dificultando ações contra a doença. Reforçar soberania em tecn...
outraspalavras.net
July 25, 2025 at 3:27 PM
"É inaceitável que, após uma luta tão longa para garantir a produção de genéricos e romper o monopólio da Gilead, o Brasil continue pagando caro pelo sofosbuvir. Permanecer pagando preços inflacionados é uma afronta ao direito à saúde e à boa gestão dos recursos públicos."
Ça m'a littéralement sauvé la vie. (Associé avec une autre molécule) . Ce qu'elle dit me terrifie. Vous avez pas idée !!
September 28, 2026 at 6:44 PM
Ça m'a littéralement sauvé la vie. (Associé avec une autre molécule) . Ce qu'elle dit me terrifie. Vous avez pas idée !!
